The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Preclinical evaluation of anti-ROR1 CAR T cells employing a ROR1 binding SCFV derived from the clinical stage mab cirmtuzumab.
 
Charles E. Prussak
Stock and Other Ownership Interests - Oncternal Therapeutics
Consulting or Advisory Role - Oncternal Therapeutics
Patents, Royalties, Other Intellectual Property - Oncternal Therapeutics
 
Christopher Oh
No Relationships to Disclose
 
Juliana Velez Lujan
No Relationships to Disclose
 
Sharon Lam
No Relationships to Disclose
 
Jieyu Zhang
No Relationships to Disclose
 
Jayde Fernandez
No Relationships to Disclose
 
Navyaa Sinha
No Relationships to Disclose
 
Jessica Pham
No Relationships to Disclose
 
Haoming Shi
No Relationships to Disclose
 
Caitlin Shin
No Relationships to Disclose
 
Gunnar F. Kaufman
Employment - Oncternal Therapeutics, Inc; Sorrento Therapeutics
Leadership - Oncternal Therapeutics, Inc
Stock and Other Ownership Interests - Oncternal Therapeutics, Inc; Sorrento Therapeutics
Patents, Royalties, Other Intellectual Property - I am the co-inventor on several patent applications assigned to Sorrento Therapeutics, Inc.
 
George F. Widhopf II
No Relationships to Disclose
 
Ezra E.W. Cohen
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Bristol-Myers Squibb; Incyte; Merck; MSD
 
Thomas J. Kipps
Employment - Moores Cancer Center
Honoraria - Abbvie; Celgene; Dava Oncology; Genentech; Gilead Sciences; Janssen; Pharmacyclics; Roche
Consulting or Advisory Role - Abbvie; Celgene; Dava Oncology; Genentech; Gilead Sciences; Janssen; Pharmacyclics; Roche
Speakers' Bureau - Verastem/Pharmacyclics
Travel, Accommodations, Expenses - Abbvie/Pharmacyclics; Bionest Partner; Breast Cancer Research Foundation; Celgene; Dava Oncology; European Research Initiative on CLL (ERIC); Genentech/Roche; German CLL Study Group (GCLLSG); Gilead Sciences; Indy Hematology Review; International Workshop on Non-Hodgkin Lymphoma; Janssen; National Cancer Institute; NCCN; OncLive; Patient Power; Shenzhen Cancer Care Center; Society of Hematologic Oncology; TG Therapeutics; University of Nebraska Medical Center; Verastem